* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Neuropathic Pain
		                    
		                    
								Survey							
                            
		                
		                
                            
                            
								Document related concepts							
                        
                        
                    
						
						
							Transcript						
					
					NEUROPATHIC PAIN Summary  Neuropathic pain – Nerve injury / compression  Comprehensive assessment helps dignosis  Multiple mechanisms  Follow step ladder for drug treatment  Treat Total Pain Neuropathic Pain Definition: International Association for the Study of Pain defines Neuropathic pain as : “ pain initiated or caused by primary lesion or dysfunction of the nervous system” Also defined as ‘Pain in an area of absent sensation’ Classification of Neuropathic Pain  Nerve Compression  Nerve Injury Central Peripheral Sympathetic Eg. Post-stroke pain Spinal Cord Compression Visceral Plexopathies Somatic peripheral neuropathy eg. post-herpetic neuralgia Common Neuropathic Pain Situations  Amputation - eg. Phantom limb pain  Back, leg, and hip problems (Sciatica)  CANCER and its treatment  Diabetes  Trigeminal neuralgia  HIV infected or AIDS  Herpes zoster virus infection  Complex Regional Pain Syndromes  Cerebro-Vascular Accident Causes of Neuropathic pain in advanced Cancer Cancer     Nerve compression / infiltration Plexopathy Spinal cord compression Thalamic tumour Debility • Postherpetic neuralgia Anticancer treatment  Chronic surgical incision pain  Phantom limb pain  Chemotherapy- peripheral neuropathy  Radiation fibrosis - Plexopathy, neuralgia Concurrent disorders • Diabetic neuropathy • Post-stroke pain Hallmarks of Neuropathic Pain Allodynia : Pain resulting from a stimulus that normally does not evoke pain. Thermal or mechanical stimuli Hyperalgesia : Something that is normally painful is now more painful than usual  Exaggerated response to a normally painful stimulus  Pain within area of injury - Primary Hyperalgesia  Pain in surrounding undamaged area - Secondary Hyperalgesia Clinical features of nerve pain Distribution:  If peripheral nerve injury - neurodermatomal  If central - larger area of abnormal sensation If Sympathetic component is present  Pain felt in area of distribution of the vessel  Vasomotor disturbances : redness, pallor, swelling  Sweating abnormalities  Motor and trophic changes - thinning of skin What Does Patient Complain of ?  Burning  Numbness  Paroxysmal  Lancinating  Shooting  Raw Skin Feeling  “ants crawling”  “bag of worms” Nerve injury NMDA and Glutamate mechanisms Dorsal horn Neuropathic Pain Hyperexcitability and spontaneous activity Central sensitization Serotonin, noradrenaline Chemical Excitation of Non-nociceptors beta Mechanisms of Neuropathic Pain 1. Chemical Excitation of non-nociceptors 2. Recruitment of nerves outside the site of injury 3. Excitotoxicity 4. Excess Sodium channels 5. Ectopic discharge 6. De-afferentation 7. Central sensitization maintained by peripheral input 8. Sympathetic involvement 9. Ephaptic cross talk Central Sensitisation - Role of NMDA Receptor • Present mainly in Dorsal Horn Cells • Increased Stimulation causes ‘Wind up’ Phenomena • Increased Excitation leads to Persisting pain Agents which increase NMDA Receptor activity: Glutamate Substance P Excessive Sodium channels Excessive Calcium channels Decreased Potassium channels Nerve Growth Factor, Nitric-oxide NERVE INJURY DRUG NEUROCHEMICAL ANATOMICAL  INCREASE IN SURVIVAL FACTORS       CELL DEATH ALTERATION OF TROPHIC FACTOR EXPRESION SYMPATHETIC SWITCH IN EXITATORY PEPTIDES SPROUTING INCREASE OF INHIBITORY PEPTIDES CHANGE IN RECEPTOR EXPRESSION INCREASE IN NITRIC OXIDE SYNTHASES CHANGE IN ION CHANNEL ALL THE ABOVE LEADS TO PHYSIOLIGICAL CHANGES LIKE REDUCTION IN PRESYNASPTIC INHIBITION ECTOPIC DISCHARGES NERVE INJURY DORSAL HORN NEUROCHEMICAL REDUCTION IN GABA AND GABA RECEPTORS REDUCTION IN OPIOD RECEPTORS GLIA CELL ACTIVATION INCREASE IN CYTOKINES INCREASE IN IMMEDIATE EARLY GENES INCREASE IN TRANSCRIPTION SIGNALS ANATOMICAL TERMINAL ATROPHY CELL LOSS APOPTOSIS ALL THESE ABOVE CHANGES CAUSES INCREASED WINDUP, LONG TERM POTENTIATION REDUCED INHIBITORY CONTROLE IN DORSAL HORNS Recruitment Nerve injury + recruitment of nerves outside site of injury State of Hyperalgesia - Primary and secondary Neuroanatomical Reorganisation Recruitment to adjacent segments Ectopic Discharge Discharge of impulses from Areas of nerve which normally should not be discharging 1. Comprehensive Assessment Look for clinical features :  Allodynia - pain on touch, cant bear a draft on skin, even clothes provoke hyperesthesia  Sensory deficit, numbness.  Hyperalgesia.  Occasional sympathetic component Increased skin temperature, sweating Patients exhausted, demoralised, sleepless. ALTERED EXCITABILITY  VOLTAGE SENSITIVE NA+ CHANNELS HAVE BEEN SHOWN ACCUMALATE IN NEUROMA NERV ENDINGS & IN PATCHES OF DEMYELINATION  AXONAL NEURAL MEMBRANE UNDER MYELIN NORMALLY CONTAINS A VERY LOW DENSITY NA+ CHANNELS B’CAUSE MYELIN SUPPRESS THEIR INSERTION  DEMYELINATION, SPROUTING, ENDBULB FORMATION REMOVE THIS SUPPRESSION PERMITTING EXCESS CHANNEL INSERTION Sodium-channel Anticonvulsants Carbamazepine Valproate Gabapentin Pregabalin Clonazepam blockade Lidocaine Opioids NSAIDs Activation of GABA inhibitory system Baclofen Enhanced descending Inhibition Tricyclics SSRIs Alpha2adrenergic agonists Tramadol Inhibition of glutamate excitatory system Mechanism-based therapy Ketamine Amantidine 2. Management of Neuropathic pain  Explanation  Analgesics : specific for neuropathic pain other drugs : Non-opioids & Opioids  Interruption of pain pathways.  Physical therapy : Heat or cold pads, TENS  Psychological and modification of way of life Treatment of Neuropathic Pain NMDA receptor Coticosteroid For Nerve Compression Tricyclic antidepressant or anti-epileptic Tricyclic anti -channel blocker depressant and Step 4 anti-epileptic Invasive Techniques Step 5 Step 3 Step 2 Step 1 Try Opioids first in cancer or severe non-cancer pain Corticosteroid      INFLAMMATORY NEUROPATHIC PAIN BONE PAIN PAIN FROM BOWEL OBSTRUCTION PAIN FROM LYMPHOEDEMA HEADACHE WITH RAISED ICT ACTION Inhibits PG production—Decreses inflammation—Decreases cappilary permeability—reducing peritubular oedema Membrane stabilization---Decreases Neuronal excitability  Dexamethasone – Oral or Injection I.V. 8 - 24 mg/day for 3 days and continue with oral drug in diminishing dose T Nerve After Corticosteroid T Nerve Step 1 - Opioids In Neuropathic pain related to Cancer :  More than one pain often present  Try opioids first  50% of pain may be reduced with opioids  helps reduce dose of specific neuropathic pain drugs Step 2 - TriCyclic Antidepressants Amitryptiline :  Particularly in burning type of pain  Action : Prevention of reuptake of serotonin& Norad Alfa adrenergic blockade Na channel effect, NMDA antagnsm  Start with 10 to 25 mg at night and increase every third day up to 75 to 100 mg if necessary  Side effects - sedation, constipation, urinary retention, heart block aggravated Other TCAs - Step 2 / Step 3 - Anticonvulsants  Preferred for shooting lancinating type of pain  Action : Suppress spontaneous neuronal discharges & hyperexcitability Depress the exitatory pathways, Facilitates the inhibitory mechanisms  Drugs used: Carbamazepine , sodium valproate Carbamazepine : 100 - 200mg/day increased every third day by 100 mg up to 400 - 800 mg/day Side effects : gastric irritation, sedation, giddiness, ataxia, confusion Anticonvulsants GABAPENTIN &PREGABALIN ACTION- Act on neither GABA nor Na channels Modulate the cellular Ca influx into nociceptive neurons by binding to vlotage gated Ca channels  preferred in Post Herpetic Neuralgia & Diabetic neuropathy  less side effects  Expensive Dose of Gabapentin: Start with 200 to 300 mg/day , increase up to 1200 to 1800 mg/ day in divided doses. Dose of Pregabalin : Start with 75 mg 12Qh, increase by adding 75mg every 3 to 4 days, upto 300 mg Q12h NMDA Receptor Antagonists Oral Ketamine :   Injectable form: given mixed in sweetened beverage Starting dose : 0.25 to 0.5 mg/kg (approximately 25mg /adult dose) 4 - 6 hourly - gradually increased  Side effects : delirium, hallucinations, nightmares Systemic Local Anaesthetics  Action- Blocking the Na channels  Ex-Lidocaine,Mexilitine Autonomic drugs  Alfa2 Agonist- Clonidine  Alfa1 Antagonist- Prazocin,Terazocine  Othrs like CAPSAICIN CREAM Interventional Techniques  Sympathetic Blockade eg. Lumbar Sympathetic block for pelvic or lower limb pain (e.g. Ca cervix) Stellate Ganglion block for upper limb pain as in Ca Breast  Trigger Point Injections  Somatic Nerve Block  Neurolytic block  Epidural What should be the aim of our treatment ? To improve quality of life ! Non-Physical Components of Pain Physical Psychological Total Pain Spiritual Social
 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
                                             
                                             
                                             
                                             
                                             
                                             
                                             
                                             
                                             
                                             
                                            